Pelthos Therapeutics logo
Pelthos Therapeutics
PTHS | AMEX
Chart Builder DCF Calculator
$7.15
-$0.29 (-3.90%)
At close: Nov 16, 2026, 4:00 PM ET
$7.15
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:00 PM ET

Pelthos Therapeutics Company Profile

Company profile explained

Company Profile

Pelthos Therapeutics Inc. operates as a biopharmaceutical enterprise dedicated to developing and commercializing innovative medical treatments that address significant, unmet patient needs. Its primary offerings include ZELSUVMI, a medication specifically indicated for the treatment of molluscum contagiosum in individuals aged one year and older. Furthermore, the company leverages NITRICIL, an exclusive technological platform grounded in nitric oxide research. Established in 2002, this Durham, North Carolina-based firm was previously known as Channel Therapeutics Corporation, before rebranding to Pelthos Therapeutics Inc. in July 2025.

Key Executives

Name Position
Scott Plesha Chief Executive Officer, President & Director
John Gay CFO, Secretary & Treasurer
Sai Rangarao Chief Commercial Officer

Latest SEC Filings

Date Type Title
Oct 30, 2026 425 Filing
Oct 30, 2026 425 Filing
Oct 30, 2026 8-K Current Report
May 28, 2026 8-K Current Report
May 26, 2026 4 Filing
May 22, 2026 144 Filing
May 21, 2026 8-K Current Report
May 18, 2026 4 Filing
May 15, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
May 14, 2026 8-K Current Report
View All SEC Filings ➞
Pelthos Therapeutics
Pelthos Therapeutics logo
Country United States
IPO Date Feb 16, 2024
Industry Biotechnology
Sector Healthcare
Employees 92
CEO Scott Plesha

Contact Details

4020 Stirrup Creek Drive, Suite 110, Durham, NC 27703 Durham, North Carolina 27703 United States

Stock Details

Ticker Symbol PTHS
Exchange AMEX
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001919246
CUSIP Number 171126204
ISIN Number US1711262048
SIC Code 2836

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.